New Drug For Kidney Transplant Recipients Effective In Humans

Links shared publicly online about this topic.

  • 1,373
    total visits

New Drug For Kidney Transplant Recipients Effective In Humans

medicalnewstoday.com

Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also

View full resource at medicalnewstoday.com

Tags: Kidney Health, Urinary System, Organ Transplantation, Kidney Transplant, Drug, Belatacept, Transplantation

  • Share

Most Recently Shared on February 18, 2010 at 4:09 pm By:

mnt_clinical MNT Clinical Trials

New Drug For Kidney Transplant Recipients Effective In Humans http://mnt.to/3xLW #clinicaltrials

2 years ago...

Age of Live Kidney Donor Makes Little Difference in Organ's Health - Drugs.com MedNews

drugs.com — “The age of a live kidney donor has little effect on the long-term health of a transplanted kidney in recipients older than age 39, a new study says. The findingView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 1:07 am By:

Drugs_Devices Drugs and Devices OW OW Health

Age of Live Kidney Donor Makes Little Difference in Organ's Health: THURSDAY, March 22 -- The age of a liv... http://t.co/ohcQ5hwC #drug

2 months ago...

New kidney transplant drug effective in humans, UCSF study finds - UCSF News Office

news.ucsf.edu — “New kidney transplant drug effective in humans, UCSF study finds - UCSF News OfficeView full resource at news.ucsf.edu

  • View Related
  • Share

Most Recently Shared on February 19, 2010 at 4:23 pm By:

ucsf UCSF Medical School

News brief: New kidney transplant drug effective in humans, #UCSF study finds #nephrology #pharma #transplants -- http://j.mp/dpqSu6

2 years ago...

New drug for kidney transplant recipients effective in humans

eurekalert.org — “Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class co-stimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on February 17, 2010 at 4:20 pm By:

EurekAlertAAAS EurekAlert! Health News

New drug for kidney transplant recipients effective in humans : http://eurekalert.org/e/3b3s #EurekAlert

2 years ago...

New drug for kidney transplant recipients effective in humans

eurekalert.org — “Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class co-stimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on February 17, 2010 at 3:40 pm By:

kidneynotes Kidney Notes Health News Feed

Belatacept shown to be beneficial in routine transplant immunosuppression. http://bit.ly/92qvNV

2 years ago...

Advertisement